UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000043196
Receipt No. R000049299
Scientific Title Protective efficacy of the nose gargle for the common cold symptom
Date of disclosure of the study information 2021/01/31
Last modified on 2021/08/18 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Protective efficacy of the nose gargle for the common cold symptom
Acronym Protective efficacy of the nose gargle for the common cold symptom
Scientific Title Protective efficacy of the nose gargle for the common cold symptom
Scientific Title:Acronym Protective efficacy of the nose gargle for the common cold symptom
Region
Japan

Condition
Condition common cold symptom
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Protective efficacy of the nose gargle
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes three months later nose gargle start

The number of patients that had a cold
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Behavior,custom
Interventions/Control_1 For three months, they do a nose gargle in 120 ml of 0.9% saline once a day
Interventions/Control_2 For three months, they do not a nose gargle
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
55 years-old >=
Gender Male and Female
Key inclusion criteria The voluntary participants to this study among the staffs and the Institute of associate nursing students of the Self Defense Forces Sendai Hospital in 2021 years.
Key exclusion criteria The patients who has an upper respiratory tract disease such as acute otitis media, allergic rhinitis, sinusitis, pharyngitis, pneumonia
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Tsugumi
Middle name
Last name Fukunaga
Organization Self-Defense Forces Sendai Hospital
Division name clinical department
Zip code 9830041
Address 1-1, Minaminometate, Miyagino-ku, Sendai-shi
TEL 08020922779
Email pokethrush@yahoo.co.jp

Public contact
Name of contact person
1st name Tsugumi
Middle name
Last name Fukunaga
Organization Self-Defense Forces Sendai Hospital
Division name clinical department
Zip code 9830041
Address 1-1, Minaminometate, Miyagino-ku, Sendai-shi
TEL 08020922779
Homepage URL
Email pokethrush@yahoo.co.jp

Sponsor
Institute Self-Defense Forces Sendai Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Self-Defense Forces Sendai Hospital
Address 1-1, Minaminometate, Miyagino-ku, Sendai-shi
Tel 022311111
Email pokethrush@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 01 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 01 Month 31 Day
Date of IRB
2021 Year 01 Month 21 Day
Anticipated trial start date
2021 Year 01 Month 31 Day
Last follow-up date
2021 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 01 Month 31 Day
Last modified on
2021 Year 08 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049299